bioMérieux
BIM
Performance
About bioMérieux
bioMérieux is a global leader in in vitro diagnostics, developing, producing and delivering diagnostic tests that help clinicians diagnose infections, monitor antimicrobial resistance, ensure food safety, and support pharmaceutical quality control. With a long history dating back to 1963, the company serves hospital laboratories, point-of-care settings, and the food safety and quality sectors, delivering rapid, accurate results that improve patient outcomes and public health. The German-language pages highlight a local presence in Germany while emphasizing its worldwide mission to advance diagnostic solutions and education for healthcare professionals.
Recent News
BioMérieux Unveils BIOFIRE SPOTFIRE Molecular Testing Solution for Biopharma
Seer Names Anthony Bazarko CCO to Accelerate Global Proteomics Sales
Astorg to Acquire Thermo Fisher’s Microbiology Unit for $1.1 Billion
Study Shows Limits of Rapid Antibiotic Susceptibility Testing
CES 2026: Follow Live as NVIDIA, Lego, AMD, Amazon, and More Make Their Big Reveals
Baebies’ Finder Platform Secures Dual FDA Clearance and CLIA Waiver
Ultra-Rapid Nanoplasmonic Colorimetry in Microfluidics for Antimicrobial Susceptibility Testing Directly From Specimens
Recent Deals
No recent deals for this company.